tiprankstipranks
Aligos Therapeutics, Inc. (ALGS)
NASDAQ:ALGS
Want to see ALGS full AI Analyst Report?

Aligos Therapeutics (ALGS) Revenue

470 Followers

Aligos Therapeutics Revenue

Aligos Therapeutics had a revenue of 27.78M in the quarter ending Jun 30, 2026, with 881.55%. This bring the company's revenue in the last twelve months to 31.52M, Decreased 569.88%. In the fiscal year ending Dec 31, 2025, Aligos Therapeutics had annual revenue of 2.19M with -44.59% growth.
Revenue (ttm)
31.52M
Revenue Growth
893.01%
P/S Ratio
19.68
Revenue/Employee
$26,659
Employees
82
Market Cap
$43.03M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
2.19M-1.76M-44.59%
Dec 31, 2024
3.94M-11.58M-74.60%
Dec 31, 2023
15.53M1.62M+11.66%
Dec 31, 2022
13.91M9.55M+219.04%
Dec 31, 2021
4.36M+∞%
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018